Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 2
1966 1
1967 2
1968 1
1969 1
1970 4
1971 2
1973 3
1974 8
1975 4
1976 6
1977 6
1978 1
1979 5
1980 5
1981 1
1982 1
1983 9
1984 11
1985 5
1986 4
1987 5
1988 3
1989 6
1990 12
1992 11
1993 15
1994 24
1995 19
1996 22
1997 11
1998 21
1999 33
2000 39
2001 24
2002 19
2003 25
2004 26
2005 37
2006 26
2007 48
2008 55
2009 42
2010 46
2011 51
2012 65
2013 79
2014 109
2015 91
2016 96
2017 105
2018 97
2019 136
2020 140
2021 126
2022 83
2023 69
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

1,688 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Digestive system neuroendocrine neoplasm"
Page 1
Evaluation and Management of Neuroendocrine Tumors of the Pancreas.
Scott AT, Howe JR. Scott AT, et al. Surg Clin North Am. 2019 Aug;99(4):793-814. doi: 10.1016/j.suc.2019.04.014. Epub 2019 May 27. Surg Clin North Am. 2019. PMID: 31255207 Free PMC article. Review.
Pancreatic neuroendocrine tumors are a diverse group of neoplasms with a generally favorable prognosis. ...This review provides a concise summary of the presentation, diagnosis, surgical management, and systemic treatment of pancreatic neuroendocrine
Pancreatic neuroendocrine tumors are a diverse group of neoplasms with a generally favorable prognosis. ...This review …
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ, Hou BH. Ma ZY, et al. World J Gastroenterol. 2020 May 21;26(19):2305-2322. doi: 10.3748/wjg.v26.i19.2305. World J Gastroenterol. 2020. PMID: 32476795 Free PMC article. Review.
Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with complicated treatment options that depend on pathological grading, clinical staging, and presence of symptoms related to hormonal secretion. ...Therefore, the currently availabl …
Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with complicated treatment options that de …
Neuroendocrine neoplasms of the appendix, colon and rectum.
Volante M, Grillo F, Massa F, Maletta F, Mastracci L, Campora M, Ferro J, Vanoli A, Papotti M. Volante M, et al. Pathologica. 2021 Feb;113(1):19-27. doi: 10.32074/1591-951X-230. Pathologica. 2021. PMID: 33686307 Free PMC article. Review.
Neuroendocrine neoplasms of the appendix, colon and rectum are classified according to the most recent WHO classification as neuroendocrine tumors (NET), neuroendocrine carcinomas (NEC) and mixed neuroendocrine-non neuroendocrine neoplasm
Neuroendocrine neoplasms of the appendix, colon and rectum are classified according to the most recent WHO classification as neuro
What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing.
Assarzadegan N, Montgomery E. Assarzadegan N, et al. Arch Pathol Lab Med. 2021 Jun 1;145(6):664-677. doi: 10.5858/arpa.2019-0665-RA. Arch Pathol Lab Med. 2021. PMID: 32233993 Free PMC article. Review.
.-: The 5th edition of the World Health Organization classification of digestive system tumors discusses several advancements and developments in understanding the etiology, pathogenesis, and diagnosis of several digestive tract tumors. OBJECTIV …
.-: The 5th edition of the World Health Organization classification of digestive system tumors discusses several advanc …
(177)Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP; NETTER-1 investigators. Strosberg JR, et al. Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15. Lancet Oncol. 2021. PMID: 34793718 Clinical Trial.
Patients were 18 years and older with locally advanced or metastatic, well differentiated, somatostatin receptor-positive midgut neuroendocrine tumours (Karnofsky performance status score 60) and disease progression on fixed-dose long-acting octreotide. Patients were rando …
Patients were 18 years and older with locally advanced or metastatic, well differentiated, somatostatin receptor-positive midgut neuroend
Neuroendocrine Tumors.
Basuroy R, Srirajaskanthan R, Ramage JK. Basuroy R, et al. Gastroenterol Clin North Am. 2016 Sep;45(3):487-507. doi: 10.1016/j.gtc.2016.04.007. Gastroenterol Clin North Am. 2016. PMID: 27546845 Review.
Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for other disorders initially. The diagnostic workup to characterize tumor behaviour and prognosis focuses
Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which h
Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouché O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P. de Mestier L, et al. Neuroendocrinology. 2017;105(4):412-425. doi: 10.1159/000475527. Epub 2017 Aug 12. Neuroendocrinology. 2017. PMID: 28803232 Free article. Review.
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) are a heterogeneous subgroup of rare neoplasms that represent about a third of all poorly differentiated neuroendocrine carcinomas (PDNEC). MiNEN combine a neuroendocrine component, usually a PD …
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) are a heterogeneous subgroup of rare neoplasms that represent about …
Diagnosis of digestive system tumours.
Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA; WHO Classification of Tumours Editorial Board. Washington MK, et al. Int J Cancer. 2021 Mar 1;148(5):1040-1050. doi: 10.1002/ijc.33210. Epub 2020 Nov 19. Int J Cancer. 2021. PMID: 32674220 Free article. Review.
The first volume to be produced is on the classification of Digestive System tumours, replacing the successful 2010 version. It has been rewritten and updated accordingly. ...This makes the classification relevant to many disciplines involved in the care of patients …
The first volume to be produced is on the classification of Digestive System tumours, replacing the successful 2010 version. I …
Physins in digestive system neoplasms.
Liu L, Yao X, Wang Y, Hu R, Fan C, Gong H, Liu J, Guo Y. Liu L, et al. Adv Clin Chem. 2022;111:157-176. doi: 10.1016/bs.acc.2022.08.002. Epub 2022 Nov 10. Adv Clin Chem. 2022. PMID: 36427909
The physin family of proteins, synaptophysin (SYP), synaptophysin like 1 (SYPL1), synaptophysin like 2 (SYPL2) and synaptoporin (SYNRP), are tetratransmembrane transport vesicle proteins distributed throughout the digestive system. Of these, SYP is a required marker …
The physin family of proteins, synaptophysin (SYP), synaptophysin like 1 (SYPL1), synaptophysin like 2 (SYPL2) and synaptoporin (SYNRP), are …
Mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system: A mini-review.
Toor D, Loree JM, Gao ZH, Wang G, Zhou C. Toor D, et al. World J Gastroenterol. 2022 May 21;28(19):2076-2087. doi: 10.3748/wjg.v28.i19.2076. World J Gastroenterol. 2022. PMID: 35664032 Free PMC article. Review.
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) are rare mixed tumors containing both neuroendocrine (NE) and non-NE components. ...This mini review summarizes our current understanding of MiNENs and outline diagnosis, prognosis, and …
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) are rare mixed tumors containing both neuroendocrine
1,688 results